PRICING POLICY FOR THE CLINICAL TRIALS
PRICING POLICY FOR THE CLINICAL TRIALS
- The prices for file evaluation by PROKOM has been determined by the Revolving Fund Executive Board with reference to the suggestions of the Faculty Administrative Board and the approval by the Hospital Administrative Board and all trial related prices are arranged as follows:
- The application fee is 15000 TL for the interventional studies and medical device studies supported by the Industry, and 10000 TL for observational studies. An additional application fee of 5000 TL is charged for the evaluation of each application for budget changes in the protocol.
- No application price is required fort he trials supported by the governmental sources (TÜBİTAK, BAP etc)
- Prices of health services included in clinical trials, has been determined as 5 times the prices in the Public Service Sales Tariff. And the prices of the transactions not included in the Public Service Sales Tariff and its annexes are invoiced by adding 50% of the transaction price in the Health Implementation Communiqué. Application prices are updated at the beginning of each financial year.